Share ownership Diaceutics PLC

DXRX

GB00BJQTGV64

Business Support Services

Delayed London S.E. 09:45:59 2026-09-18 EDT			5-day change	1st Jan Change
169.00 ^GBX	+2.42%		+6.96%	+32.03%

08-20	Diaceutics and Precision Cancer Consortium Launch Ngs Concordance Study to Advance Precision Oncology and Support Informed Biomarker Testing	CI
07-29	Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026	CI

Share class: Diaceutics PLC

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	85,406,423	61,469,073 ( 71.97 %)	252,063 ( 0.2951 %)	71.97 %

Major shareholders: Diaceutics PLC

Name	Stocks	%	Valuation
Gresham House Asset Management Ltd. (Investment Management) 13.51 %	11,502,591	13.51 %	22 M p
Canaccord Genuity Wealth Ltd. 6.139 %	5,227,414	6.139 %	10 M p
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 4.709 %	4,009,764	4.709 %	8 M p
Gresham House Asset Management Ltd. 4.528 %	3,855,155	4.528 %	8 M p
TrinityBridge Ltd. 3.807 %	3,242,000	3.807 %	6 M p
BlackRock Investment Management (UK) Ltd. 3.188 %	2,714,165	3.188 %	5 M p
West Elk Capital LLC 2.987 %	2,543,281	2.987 %	5 M p
Danske Bank A/S (Investment Management) 2.98 %	2,537,612	2.98 %	5 M p
Maven Capital Partners UK LLP 2.868 %	2,442,259	2.868 %	5 M p
Octopus Investments Ltd. 2.818 %	2,399,213	2.818 %	5 M p
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	55.72%
Unknown	44.28%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom	43.16%
Germany	5.55%
United States	2.99%
Denmark	2.98%
Thailand	0.57%
Netherlands	0.47%

Based on 1000 largest holdings

Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.

Employees

205

Sector

Business Support Services

Calendar

09-22 Earnings release - Q2 2026

More about the company